Exponent, Inc. (EXPO)

Market Cap	3.35B -19.3%
Revenue (ttm)	536.76M +3.5%
Net Income	106.01M -2.7%
EPS	2.07 -1.9%
Shares Out	49.25M
PE Ratio	32.87
Forward PE	27.77
Dividend	$1.24 (1.82%)
Ex-Dividend Date	Mar 6, 2026

Volume	875,263
Open	68.95
Previous Close	68.12
Day's Range	67.03 - 69.61
52-Week Range	63.25 - 83.92
Beta	0.80
Analysts	Buy
Price Target	88.00 (+29.32%)
Earnings Date	Apr 30, 2026

About EXPO

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and ...

• Industry: Engineering & Construction
• Sector: Industrials
• IPO Date: Aug 17, 1990
• Employees: 1,212
• Stock Exchange: NASDAQ
• Ticker Symbol: EXPO
• Website: https://www.exponent.com

Financial Performance

In fiscal year 2025, Exponent's revenue was $536.76 million, an increase of 3.52% compared to the previous year's $518.49 million. Earnings were $106.01 million, a decrease of -2.75%.

Analyst Summary

According to 3 analysts, the average rating for EXPO stock is "Buy." The 12-month stock price target is $88.0, which is an increase of 29.32% from the latest price.

Price Target

$88.0

(29.32% upside)

Analyst Consensus: Buy